MedTrace Logo

Strategies To Prevent Pneumonia 2 (SToPP2)

NCT00893763 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 314

Last updated 2016-01-11

Study results available
· View outcomes & findings →

Summary

Ventilator-associated pneumonia (VAP) is a serious complication in mechanically ventilated critically ill patients. The intervention tested in this project (swabbing the mouth with chlorhexidine before the endotracheal tube is inserted) could reduce the risk of ventilator-associated pneumonia.

Conditions

  • Infections, Hospital
  • Ventilator-Associated Pneumonia
  • Mechanical Ventilation Complication

Interventions

PROCEDURE

Pre-intubation CHX

Oral application of 5 ml CHX gluconate 0.12% solution pre-intubation, and 5 ml CHX gluconate 0.12% solution twice a day following intubation.

PROCEDURE

Control

No pre-intubation intervention, 5 ml CHX gluconate 0.12% solution twice a day following intubation

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • University of South Florida

    lead OTHER

Principal Investigators

  • Cindy L Munro, RN,ANP,PHD · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00893763 on ClinicalTrials.gov